Latest Articles

Subject

Article
Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease
Peter Maat, Janet W. de Beukelaar, Casper Jansen, et al.

November 12, 2015
Article
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
Yazhong Tao, Xin Zhang, Robert Zivadinov, et al.

November 12, 2015
Article
Vasculitic neuropathy following exposure to minocycline
John M. Baratta, P. James B. Dyck, Patricio Brand, et al.

November 12, 2015
Article
Glatiramer acetate treatment negatively regulates type I interferon signaling
Nicolas Molnarfi, Thomas Prod'homme, Ulf Schulze-Topphoff, et al.

November 09, 2015
Article
Myeloid cells as target of fingolimod action in multiple sclerosis
Marco Di Dario, Emanuela Colombo, Chiara Govi, et al.

November 04, 2015
Article
Fulminant demyelinating encephalomyelitisInsights from antibody studies and neuropathology
Franziska Di Pauli, Romana Höftberger, Markus Reindl, et al.

November 04, 2015
Article
Intrathecal immunoglobulin A and G antibodies to synapsin in a patient with limbic encephalitis
Johannes Piepgras, Markus Höltje, Carolin Otto, et al.

November 04, 2015
Article
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants
Sterling B. Ortega, Venkatesh P. Kashi, Khrishen Cunnusamy, et al.

November 04, 2015
Article
Effect of vitamin D on MS activity by disease-modifying therapy class
Dalia L. Rotstein, Brian C. Healy, Muhammad T. Malik, et al.

October 29, 2015
Article
7T MRI in natalizumab-associated PML and ongoing MS disease activityA case study
Tim Sinnecker, Jalal Othman, Marc Kühl, et al.

October 29, 2015

Pages